Ramsay Générale de Santé SA (EPA:GDS)
France
· Delayed Price · Currency is EUR 10.85
+0.20 (1.88%)
At close: Mar 6, 2026
Ramsay Générale de Santé Revenue
Ramsay Générale de Santé had revenue of 2.59B EUR in the half year ending December 31, 2025, with 9.24% growth. This brings the company's revenue in the last twelve months to 5.32B, up 4.90% year-over-year. In the fiscal year ending June 30, 2025, Ramsay Générale de Santé had annual revenue of 5.24B with 4.70% growth.
Revenue (ttm)
5.32B
Revenue Growth
+4.90%
P/S Ratio
0.22
Revenue / Employee
133.10K
Employees
40,494
Market Cap
1.20B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 5.24B | 235.50M | 4.70% |
| Jun 30, 2024 | 5.01B | 305.00M | 6.49% |
| Jun 30, 2023 | 4.70B | 400.50M | 9.31% |
| Jun 30, 2022 | 4.30B | 278.40M | 6.92% |
| Jun 30, 2021 | 4.02B | 276.40M | 7.38% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Nanobiotix | 10.16M |
| Clariane SE | 5.31B |
| DBV Technologies | 4.69M |
| Inventiva | 16.97M |